Prosecutors Say Drugmaker Indivior Lied About Popular Opioid Treatment
- Justice Department says company misled doctors on Suboxone
- Stock falls to lowest since split from Reckitt Benckiser
A person holds a prescription for Suboxone at her home in Lewisville, N.C., on March 11.
Photographer: Eamon Queeney/The Washington Post via Getty ImagesThis article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
Indivior Plc plummeted to an all-time low after U.S. prosecutors said the U.K. drugmaker deceived doctors about its addiction treatment’s dangers, fueling a deadly epidemic of opioid abuse.